HER2/Neu Positive Active Not Recruiting Phase 2 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0037939 (HER2/Neu Positive)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00684983Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast CancerTreatment